1 Oxotremorine, methyloxotremorine, pilocarpine or arecoline were given intravenously to anaesthetized cats, dogs or rats, and intraperitoneally to conscious normotensive and spontaneously hypertensive rats, pretreated with doses of methylatropine that completely blocked peripheral muscarinic receptors, to ascertain their effects on blood pressure and heart rate. 2 Oxotremorine but not methyloxotremorine produced a prolonged hypotension in cats and dogs but not in rats. Heart rate was not changed. Pilocarpine, although less potent, produced an identical effect, whereas the effect of arecoline was short by comparison. The hypotensive effect of these drugs was reversed by atropine. 3 In dogs, oxotremorine produced a prolonged hypotension with no change in heart rate or cardiac output.
Introduction
Oxotremorine was first reported by Cho, Haslett & Jenden (1962) to be a muscarinic agent equal in potency to acetylcholine but completely devoid of nicotinic activity. These authors found that a large intravenous dose of oxotremorine (0.05 gmol/kg), produced a prolonged hypotension and bradycardia in anaesthetized cats that was completely reversed by methylatropine, a quaternary derivative of atropine that does not readily penetrate the brain (Herz, Teschemacher, Hofstetter & Kurz, 1965) . They attributed the hypotension, therefore, solely to an action of oxotremorine on postganglionic cholinoceptors. M.J. Hosko observed, during an investigation of the central pharmacology of oxotremorine, that it produced a transient hypotension without a bradycardia in anaesthetized cats pretreated with methylatropine, suggesting an action other than on postganglionic 0007-1188/79/010015-07 $01.00 6.5.1. 65I cholinoceptors (unpublished results). The present experiments describe a prolonged hypotensive action of oxotremorine and pilocarpine that is not antagonized by methylatropine.
Methods
Blood pressure and heart rate Mongrel cats (2.5 to 3.8 kg) and dogs (9.4 to 18.3 kg) of either sex were anaesthetized with sodium pentobarbitone (32 mg/kg, i.v.) . Rats were anaesthetized with chloralose (60 mg/kg, i.p.) and urethane (600 mg/kg, i.p.). Spontaneously hypertensive rats refer to the Kyoto Wistar strain of Okamoto & Aoki (1963 Snedecor & Cochran (1967) . Comparisons of paired samples were made by the t test. Significance was taken as P < 0.05.
Results
Six cats of either sex weighing between 2.2 and 3.4 kg were anaesthetized with chloralose (55 mg/kg, i.v.). The dorsal surface of the midbrain was exposed and decerebration was carried out by sectioning the brain between the superior and the inferior colliculi. These cats were artificially respired with a positive pressure respirator.
Spinal cats
Five cats of either sex weighing between 2.1 and 3.0 kg were anaesthetized with ether. Their spinal cords were transected at the level of the first cervical vertebra, and the cats were artificially respired with a positive pressure respirator. The cats were allowed sufficient time to recover from the ether anaesthesia before drug administration. Figure 1 . A typical brief vasodrepressor response was observed following both 0.01 and 0.05 gimol/kg doses of these drugs. However, after the 0.05 gmol/kg dose of oxotremorine, the initial vasodepressor response was followed by a prolonged hypotension. A prolonged hypotension was also observed with this dose of oxotremorine after the administration of methylatropine, but it was no longer associated with a bradycardia. By contrast, both the hypotension and tachycardia elicited by methacholine were completely inhibited by methylatropine.
Increasing the dose of oxotremorine in increments from 0.05 to 0.4 imol/kg resulted in a progressively greater hypotension in six cats pretreated with methylatropine, as is shown in Figure 2 . The hypotension following each dose of oxotremorine was sustained for the entire 60 min interval between doses. Atropine (0.4 gmol/kg) administered 60 min after the last dose of oxotremorine completely reversed the hypotension within 15 min.
As had been observed with oxotremorine, both pilocarpine (1.2 to 4.8 gmol/kg) and arecoline (0.2 to 0.6 gmol/kg) decreased mean blood pressure in cats pretreated with methylatropine (3.5 jtmol/kg) (Table 1) . However, the hypotensive response produced by arecoline was less intense and short lasting (2 to 5 min). In addition, increasing the dose of arecoline to 1.9 gmol/kg, in two cats did not produce any additional blood pressure decrease, suggesting a much weaker hypotensive activity compared to oxotremorine. On the other hand, the hypotensive response produced by pilocarpine was long lasting (> 60 min) and qualitatively similar to that produced by oxotremorine. The hypotensive response produced by both Cardiovascular effects of oxotremorine in dogs and rats
The fall in blood pressure produced by oxotremorine following methylatropine pretreatment could be (Table 3) . This effect was readily and completely reversed by a single 0.44 p.moljkg dose of atropine. By contrast, in 5 spinal cats pretreated with methylatropine, mean blood pressure did not change following doses of oxotremorine as large as 0.20 ,tmol/kg (Table 3 ).
The hypotension elicited by doses of oxotremorine 0.05 Jtmol/kg and larger consisted of an immediate, brief vasodepressor response and a secondary long lasting hypotension. The immediate vasodepressor response resulted from an action on peripheral muscarinic receptors since it is effectively inhibited by methylatropine (Cho et al., 1962) . The secondary, long lasting hypotension seemed to result from an action in (6) Spinal (5) --r -----------the central nervous system since it was not prevented by methylatropine, a muscarinic receptor blocking agent that does not readily penetrate the brain (Herz et al., 1965) , but it was readily reversed by atropine. This was substantiated when a similar hypotension was not observed with methyloxotremorine, a potent quaternary analogue of oxotremorine that also does not readily penetrate into the central nervous system (Hanin, Jenden & Cho, 1966) . The persistence of the hypotensive action of oxotremorine following decerebration and its absence in spinal cats suggests a site of action in the brain stem. This is consistent with the observations of Guertzenstein (1973) and Edery & Guertzenstein (1974) that carbachol decreased blood pressure when applied locally to a discrete area on the ventral surface of the brain stem.
The lack of effect of oxotremorine in the spinal cat, a preparation with a low degree of sympathetic tone, suggests the importance of the sympathetic nervous system in the hypotensive action of oxotremorine. Schmitt, Schmitt & Fenard (1972) reported decreases in both blood pressure and sympathetic nerve activity in cats after oxotremorine, but these 2 actions did not appear to be associated. The hypotension was reversed by methylatropine suggesting a peripheral action, whereas the decreased spontaneous sympathetic nerve activity was reversed by atropine but not methylatropine suggesting a central action. The concomitant decrease in both blood pressure and spontaneous sympathetic nerve activity in the present experiments following methylatropine and their reversal by atropine suggest both effects result from an action of oxotremorine in the brain stem. In atropinized animals, the re-establishment of both effects by large doses of oxotremorine suggests a central muscarinic mechanism that may be competitive.
The importance of such a system in blood pressure control is not known. However, the lack of effect of atropine alone on blood pressure suggests that the inhibitory system stimulated by oxotremorine is not tonically active.
It is interesting that both clonidine (see van Zwieten, 1975) and oxotremorine produce identical effects on blood pressure and sympathetic nerve activity by actions at different receptors but do not affect heart rate in the same way; the bradycardia reported for clonidine (Magnus & Long, 1968) was not observed with oxotremorine suggesting an action at different neurones in separate pathways within the brain. Clonidine has also been reported to decrease cardiac output (Hoefke & Kobinger, 1966) but oxotremorine does not. The hypotensive action of oxotremorine appears to result solely from a decrease in peripheral resistance.
The hypotensive activity of oxotremorine was not unique to this molecule but could be elicited by pilocarpine as well. The weak central hypotensive activity of arecoline is in accordance with the relatively short central action of this drug (Haubrich & Reid, 1972) . Thus, the activities of oxotremorine in reducing blood pressure and sympathetic activity seem characteristic of drugs with muscarinic properties.
The lack of a hypotensive effect with oxotremorine in methylatropine pretreated rats is consistent with the observations of Brezenoff & Jenden (1969) and Brezenoff & Wirecki (1970) that the transient hypotension following micro-injections of oxotremorine into the posterior hypothalamus of rats was prevented by systemically administered methylatropine. Likewise, the rise in blood pressure observed in anaesthetized rats is consistent with the observations of Walker & Weetman (1970) . The lack of effect of oxotremorine on blood pressure in normotensive rats or spontaneously hypertensive rats that were conscious suggests an influence of anaesthesia on the oxotremorine response. The production of a pressor rather than a hypotensive response in conscious dogs by intracerebroventricular injections of cholinomimetic drugs as reported by Lang & Rush (1973) is in agreement with this. Thus, rats respond differently to oxotremorine from cats or dogs, and anaesthesia seems to influence the response.
It was concluded that oxotremorine and pilocarpine can produce a prolonged hypotension in cats and dogs but not in rats following methylatropine pretreatment. The doses required for this action are larger than those producing vasodilatation by an action on peripheral muscarinic receptors in the nonpretreated animal. The prolonged hypotensive action of these drugs is mediated by an action in the brain stem resulting in a decrease in spontaneous sympathetic nerve activity and peripheral resistance. Cardiac output and heart rate are not involved in the central hypotensive action of oxotremorine, setting this action apart from that of clonidine. 
